CM
WST icon

Cercano Management’s West Pharmaceutical WST Stock Holding History

Cercano Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-92,398
Closed -$36.6M – 114
2024
Q1 		$36.6M Buy
92,398
+22,947
+33% +$8.49M 1.02% 26
2023
Q4 		$24.5M Hold
69,451
– – 0.81% 33
2023
Q3 		$26.1M Hold
69,451
– – 0.93% 29
2023
Q2 		$26.6M Buy
69,451
+31,334
+82% +$11.2M 0.92% 29
2023
Q1 		$13.2M Sell
38,117
-1,950
-5% -$570K 0.53% 42
2022
Q4 		$9.43M Buy
+40,067
New +$9.49M 0.38% 55

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cercano Management's WST Position: Q2 2024 in Review

Cercano Management sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 92,398 shares — an estimated $36.6M sold.

Cercano Management first reported a position in WST in Q4 2022 and held it in 6 quarters. The position peaked at $36.6M in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Cercano Management reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Cercano Management sold 92,398 West Pharmaceutical shares in Q2 2024, an estimated $36.6M.
  • Cercano Management first reported a position in West Pharmaceutical in Q4 2022 and held it in 6 quarters.
  • Cercano Management's West Pharmaceutical position peaked at $36.6M in Q1 2024.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Cercano Management's 13F filing for Q2 2024, filed 13 Aug 2024.